Enteric Glia Exhibit P 2U Receptors that Increase Cytosolic Calcium by a Phospholipase C-Dependent Mechanism by Kimball, Beth C.
Journal of Neurochemistry
Lippirtcott~-RavenPublishers. Philadelphia
© 1996 International Society for Neurochemistry
Enteric Glia Exhibit P2u Receptors that Increase Cytosolic
Calcium by a Phospholipase C-Dependent Mechanism
Beth C. Kimball and Michael W. Mulholland
Department of Surgery, University of Michigan, Ann Arbor, Michigan, U.S.A.
Abstract: Calcium signaling in fura-2 acetoxymethyl es-
ter-loaded enteric glia was investigated in response to
neuroligands; responses to AlP were studied in detail.
Carbachol (1 mM), glutamate (100 jiM), norepinephrine
(10 jiM), and substance P (1 pM) did not increase the
intracellular calcium concentration ([Ca24 ],) in culturedenteric glia. An increasing percentage of glia responded
to serotonin (4%; 100 pM), bradykinin (11%; 10
1eM),
and histamine (31%; 100 pM), whereas 100% of glia
responded to ATP (100 pM). ATP-evoked calcium signal-
ing was concentration dependent in terms of the percent-
age of glia responding and the peak [Ca
2fl, achieved;
responses w re pertussis toxin ins nsitive. Based on re-
sponsiveness of enteric glia to purinergic agonists and
peak [Ca2~]evoked, ATP UTP > ADP > j3,y-methyl-
eneadenosine 5 ‘-triphosphate ©‘ 2-methylthioadenosine
5 ‘-triphosphate = ev,fl-methyleneadenosine 5 ‘-triphos-
phate = AMP = adenosine, suggesting a glial P
2~recep-
tor. Depletion of D-myo-inositol 1 ,4,5-trisphosphate-sen-
sitive calcium stores by thapsigargin (10 pM) abolished
glial responses to ATP. Similarly, calcium responses were
decreased 92% by U-73122 (10 pM), an inhibitor of
phospholipase C, and 93% by the phorbol ester phorbol
12-myristate 13-acetate (100 nM), an activator of protein
kinase C. Thus, cultured enteric glia can respond to neu-
rotransmitters with increases in [Ca
2~}. Our data sugg st
that glial responses to ATP are mediated by a Psu recep-
tor coupled to activation of phospholipase C and release
of intracellular calcium stores. Key Words: Myenteric
plexus—ATP— Purinergic receptors—Signal transduc-
tion.
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The enteric nervous system lies within the intestinal
wall, uninterrupted from the esophagous to the inter-
nal anal sphincter. Composed of neurons, glia, and
occasional fibroblasts, the enteric nervous system is
involved in the regulation of intestinal smooth muscle
contractility, absorptive-secretory epithelium, and
blood flow (Jabbur et at., 1988). Enteric glia, which
outnumber enteric neurons 2:1, display morphological
and molecular similarities to CNS astrocytes: They
have irregular shapes, do not synthesize a basal lamina,
and have an abundance of glial fibrillary acidic protein
(GFAP)(Gershon and Rothman, 1991). Traditionally,
enteric glia are described as a homogeneous population
of cells whose primary function is supporting neurons
in the continuously moving intestinal wall (Gabella,
1981).
Evidence has accumulated challenging the concept
that glial cells of the CNS and PNS are merely passive
supports for neurons. Voltage-dependent ion channels
similar to those observed in neurons have been demon-
strated in glial cells (Barres et al., 1990). Studies both
in vitro and in situ have shown functional neuroligand
receptors linked to second messenger systems on
astrocytes, oligodendroglia, and Schwann cells (Mur-
phy and Pearce, 1987; Barres, 1991; Kastritsis et al.,
1992; Kastritsis and McCarthy, 1993). Furthermore,
both neuron—glial signaling (Dani et al., 1992) and
glial—neuron signaling (Nedergaard, 1994) have been
reported.
We postulated that enteric glia, like glia in the CNS
and PNS, possess signal transduction systems that can
be stimulated by neuroactive substances. We examined
calcium signaling evoked by selected neuroligands in
fura-2 acetoxymethyl ester (fura-2lAM) -loaded en-
teric glia. Furthermore, we investigated a receptor sub-
type and intracellular mechanism of action for ATP,
which stimulated calcium fluxes in all enteric glia ex-
amined. We report that cultured enteric glia (a) re-
spond to select neurotransmitters with increases in cy-
tosolic calcium concentration, (b) are pharmacologi-
cally heterogeneous in responses to neuroligands, and
(c) possess a P
2~receptor for ATP linked to phospholi-
pase C (PLC) activation with release of intracellular
calcium stores.
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MATERIALS AND METHODS
Reagents
ATP. ADP, AMP, adenosine, UTP, a,~-methyleneadeno-
sine 5 ‘-triphosphate (a,~-MeATP),~,y-methyleneadeno-
sine 5’-triphosphate (~,y-MeATP), collagenase, trypsin-
EDTA lx, trypsin inhibitor, thapsigargin, L-glutamic acid,
penici llinl streptomycin solution, rabbit anti-GFAP, mouse
anti-microtubule-associated protein (MAP), and gel mount
were purchased from Sigma Chemical Co. (St. Louis, MO,
U.S.A.). 2-Methylthioadenosine 5 ‘-triphosphate (2-MeS-
ATP), reactive blue 2 (RB2), phorbol 12-myristate 13-ace-
tate (PMA), pertussis toxin, bradykinin, and histamine were
from Research Biochemicals International (Natick, MA,
U.S.A.). Suramin was from Calbiochem (La Jolla, CA,
U.S.A.). Thapsigargin epoxide and 4ca-PMA were from LC
Laboratories (Woburn, MA, U.S.A.). The U-73122 com-
pound was a kind gift from Dr. Stephen K. Fisher (Univer-
sity of Michigan). The U-73343 compound was from Bio-
mol (Plymouth Meeting, PA, U.S.A.). Duncan—Hartley
guineapigs were from Simonsen Labs (Gilroy, CA, U.S.A.).
flanks’ balanced salt solution, medium 199, and fetal bovine
serum were from GibcoBRL (Grand Island, NY, U.S.A.).
NU-serum was from Collaborative Research (Bedford, MA,
U.S.A.). Fura-2/AM and fura-2free acidwere from Molecu-
lar Probes (Eugene, OR, U.S.A.). Rabbit anti-human fibro-
ncctin, fluorescein-conjugated goat anti-rabbit lgG (whole
molecule), Texas red-conjugated goat anti-mouse IgG,A,M,
and fluorescein-conjugated goat F(ab’)2 fragment to mouse
lgG (whole molecule) were from Cappel Organon Teknika
Corp. (Durham, NC, U.S.A.). Rabbit anti-neuron-specific
cnolase (NSE) and rabbitanti-bovine brain S-100 were from
Dako (Carpenteria, CA, U.S.A.). Biotinylated goat anti-rab-
bit EgG (U + L) and streptavidin fluorescein were from
Amersham (Arlington Heights, IL, U.S.A.). Normal goat
serum was from Boehringer Mannheim (Indianapolis, IN,
U.S.A.).
Myenteric plexus isolation
The use and care of the Duncan—Hartley guineapigs in the
following protocols have been approved by the University
Committee on the Use and Care of Animals (approval no.
.51 82A). Dispersed primary cultures of guineapig myenteric
plexus were prepared on collagen-coated coverslips. The tae-
nia coli from 1 day-old male Duncan—Hartley guinea pigs
were removed and placed in Hanks’ balanced salt solution
plus 0.1% collagenase (type V) for 16—20 h at 4°C.After
a 35-mm incubation at 37°C,the muscle layers of the taenia
coli were separated from the myenteric plexus using a dis-
secting microscope. The plexus was trypsinized for 30 mm
at 37°Cusing trypsin-EDTA solution, triturated with silicon-
izcd flamed Pasteur pipettes of decreasing tip diameter, and
plated on collagen-coated coverslips. Cultures were exposed
to complete medium 199 plus 5% NU-serum and 0.001%
trypsin inhibitor (type I-S from soybean). Penicillinlstrepto-
mycin solution was added for the first 24 h at a 2% concentra-
tion. Antimitotic agents were not added. The cultures were
incubated at 37°Cwith 95% 0215% C02, and medium was
changed every other day.
Loading and cell preparation for imaging
Cultured plexus was incubated at 37°C in fresh warmed
tttedium containing 4 pM fura-2/AM for 30 mm. Loaded
coverslips were washed, resuspended in control buffer (pH
7.40. containing 118 mM NaCI, 4.7 mM KC1, 1.8 mM
CaC1,, 10 mM HEPES, 15 mM NaHCO1, 11 mM glucose,
0.9 mM NaH2PO4, and 0.8 mM MgSO5), and placed in an
aluminum superfusion chamber. The superfusion rate of the
control buffer and experimental solutions was 1 ml/min at
37°C.For calcium-free conditions, CaCI2 was removed from
the buffer, and 1 mM EGTA was added.
Calcium level measurements
A Zeiss (Rockville, MD, U.S.A.)Axiovert inverted micro-
scope and Attofluor digital imaging system were used for





1was calculated from the ratios of the
fluorescence intensities of fura-2 at 334 and 380 nm wave-
lengths with an emission wavelength of 500 nm (Grynkie-
wicz et al., 1985). Calibration of the system was performed
daily using fura-2 free acid and the following two-point
standardization equation: lCa
2~] = Kn I(R — R(L ))/
(R(Hi) — R)]fi, where K
0 is the dissociation constant of
the Ca
2’ /fura-2 complex (225 nm), R is the F4MIF3S , i.e.,
fluorescence at 334 nm excitation divided by the fluores-
cence at 380 nm excitation, R(Lo) is theratio at zero calcium
(1 mM EGTA), R(Hi) is the ratio at high calcium (1 mM
CaCl




Frames were not averaged to obtain images. A ratio pair
was taken every I .5 s. Calibration was done in the same
superfusion chamber using a saturating Ca2~level of 2 mM
and a zero Ca2~value of 4 mM EGTA.
Immunocytochemical staining
Immediately following a calcium imaging experiment,
coverslips were fixed in methanol (100% at —20°C), air-
dried, and stored at —40°C. For staining, coverslips were
allowed to come to room temperature, rehydrated with phos-
phate-buffered saline (PBS) for 5 mm and then blocked for
20 mm in PBS/5% fetal bovine serum with 10 drops of
normal goat serum. After the blocking solution wasremoved,
primary antibodies were immediately applied and allowed
to incubate overnight at 4°C.
Staining for NSE, fibronectin, and S-l00 was performed
as follows: Coverslips were washed twice for 5 mm in PBS,
incubated with biotinylated anti-rabbit lgG (1:100) for 1 h
at room temperature, and washed twice again in PBS. Coy-
erslips were then incubated with streptavidin-fluorescein iso-
thiocyanate (NSF and fibronectin, 1:100 dilution for both)
or streptavidin-Texas red (S-lOO, 1:100) for 1 h at room
temperature.
Staining for MAP2 and GFAP was performed as follows:
Coverslips were washed twice for 5 mm in PBS and then
incubated with goat anti-mouse-Texas red (1:20) in blocking
solution (for MAP2) or goat anti-mouse-fluorescein isothio-
cyanate fragment [F ( ab’ )s; 1:6001 in blocking solution (for
GFAP) for 30 mm at 37°C.
After a final washing in PBS, coverslips were mounted
with gel mount and stored in the dark at 4°Cuntil photo-
graphed using a Leitz Orthoplan microscope. Negative con-
trols were performed with normal mouse serum or normal
rabbit serum as appropriate.
Data presentation and calculation
Results are presented as mean ± SEM values. The sig-
nificance level was defined as p < 0.05 by Student’s t test.
A glial cell was judged to have responded to a ligand if its
[Ca24], increased by at least 100% over baseline values.
Experiments were performed on days 2—4 in vitro, and glia
examined were free from overlying myenteric neurons.
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FIG. 1. Myenteric plexus cultures from days 2—4 in vitro were incubated with anti-GEAP (primary) and goat anti-mouse fluorescein
isothiocyanate fragment (secondary) or anti-S-100 (primary) and streptavidin-Texas red (secondary). Glia stained positively for GFAP
(A) and S-lOG (B). (x250). Myenteric neurons were unstained.
Experiments using inhibitors/antagonists were done as
follows: An initial 60-s superfusion of ATP was given, fol-
lowed by a 300-s resting perfusion with buffer alone, fol-
lowed by a second superfusion of ATP plus inhibitor/antago-
nist. Thus, each responding glial cell served as its own con-
trol.
In antagonist/inhibitor studies, percent inhibition was cal-
culated using the equation 100 — 100(x), where x equals
the change in calcium level (A Ca24) of the secondexposuredivided by the A Ca24 level of the first exposure.
During experiments, enteric glia were differentiated from
neurons morphologically as well as via depolarization-in-
duced [Ca2~ f increases. Under 40x phase contrast 2—4 days
postplating, enteric glial cells are flat with a centrally placed
nucleus and wide surrounding cytoplasm. In contrast, myen-
teric neurons appear round, compact, and phase bright (Saf-
frey et al., 1991). In addition, at the end of each experiment,
coverslips were superfused with 55 mM KCI. Enteric glial
cells have not been shown to possess voltage-gated calcium
channels (Broussard et al., 1993) and thus do not respond
to KCI superfusion. In contrast, myemtcric neurons have L-
and N-type calcium channels (Hitting et al., 1990) and
increase [Ca24]
1in response to depolarization.
RESULTS
Immunocytochemical characterization of enteric
glia
Glia in myenteric plexus cultures from days 2—4
postplating were characterized immunocytochemically
using standard glial stains. Cells with distinct glial
morphology on light microscopy stained positively for
GFAP and S-l00 (Fig. I). Glia stained negatively for
fibronectin, indicating a lack of contaminating fibro-
blasts (Bannerman et al., l988). Furthermore, glia
were negative for NSE, an isoenzyme specific to neu-
rons of both the CNS and PNS (Scheuermann et al.,
1989), and MAP2, a nontubulin protein associated
with microtubules and specific for neurons (Olmstead,
1986). Myenteric neurons in these cultures stain posi-
tively for both NSE and MAP2 (Mulholland et al.,
1994). In these dispersed enteric plexus cultures at
days 2—4 postplating, enteric glia comprise the major-
ity of cells (-~~70%),with the remainder of cells being
enteric neurons (25%) and fibroblasts (5%) (Saffrey
etal., 1991).
Neuroligand-evoked calcium signaling in enteric
glia
Fura-2IAM-loaded enteric glia from days 2—4 post-
plating were exposed to neuroligands in a calcium-
containing buffer individually for 60 s from an eight-
well perfusion chamber. The exposures to agonists
were separated by continuous buffer perfusion for 300
s. Results were consistent whether ATP was added
either before or after other ligands. Over 10 coverslips
were examined with a different sequence of agonist
addition, as described by Kastritsis and McCarthy
(1993), to minimize effects, if any, of heterologous
receptor desensitization. The agonists chosen (carba-
chol, glutamate, norepinephrine, substance P, seroto-
ni bradykinin, histamine, and ATP) have been linked
to the hydrolysis of polyphosphoinositides in CNS glial
cultures (for reviews, see Murphy and Pearce, 1987;
Barres, 1991).
Baseline [Ca
2j, of enteric glia was 48 ± I (n
J. Neuroche,,,.. Vol. 66, No. 2, /996
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FIG. 2. Typical enteric glial response to ATP superfusion (100
pM, 250 s) in a calcium-containing buffer. KCI superfusion (55
mM, 60 s) does not increase [Ca2-]1in enteric glia; this lack
of response in addition to morphology differentiates glia from
myenteric neurons during experiments. This tracing is typical of
139 glial responses.
= 243). Neither spontaneous nor agonist-induced cal-
cium oscillations were seen, in contrast to fura-2/AM-
loaded astroglia (Salm and McCarthy, 1990; Kastritsis
et al., 1992). None of 80 enteric glia examined re-
sponded to carbachol, glutamate, norepinephrine, or
substance P with calcium fluxes. One of 23 glia (4%)
responded to serotonin (100 pM), whereas nine of 81
glia (I 1%) responded to bradykinin (10 pM) and 25
of 81(31%) responded to histamine (100 pM). ATP
(100 pM) consistently evoked calcium transients in
100% of glia examined (81 of 81). ATP-induced tran-
sients in calcium-containing buffer were biphasic, with
a sharp peak followed by a sustained elevation main-
tained during the presence of the agonist (Fig. 2).
This sustained elevation appeared to require continued
agonist exposure, as it was not observed with shorter
agonist exposures (60 s), as will be evident in suc-
ceeding figures. Because cultured enteric glia univer-
sally responded to ATP, we further investigated a re-
ceptor subtype and intracellular signal transduction
mechanism mediating ATP’s action.
FIG. 3. Concentration-dependent increases in peak [Ca
2~]~
evoked by ATP in enteric glia. The total number of glia examined
was 352; each glial cell was exposed to a single ATP concentra-
tion. * p < 0.05 versus basal value by Student’s t test.
FIG. 4. Effect of multiple exposures to ATP. Repetitive superfu-
sion ofenteric glia with ATP (100 ysM, 60 s) in calcium-containing
buffer, separated by 300 s of buffer perfusion, evoked decreas-
ing peak [Ca2~],responses. This tracing is typical of 68 glial
responses.
ATP-evoked concentration-dependent calcium
transients in enteric glia
Glia did not respond to ATP at a concentration of
0.01 pM. Eleven percent of cells responded to 0.5 pM
ATP, 45% of cells responded to 1.0 pM ATP, and
100% of glia responded to ATP at concentrations of
10, 100, and 1,000 pM (total glia examined = 352).
Responses were judged to be an increase in [Ca24],
by at least 100% over basal levels during ATP expo-
sure. As the ATP concentration increased, the stimu-
lated peak [Ca24]
1 increased as well (Fig. 3). In single
glial cells, repetitive ATP exposures (0.5—1,000 pM)
given between 300-s rest intervals of control buffer
produced progressive decreases in [Ca
2~]
1 responses
(Fig. 4). There was a 41% decrease in peak [Ca
24 11
between the first nd secon ATP exposures in cal-
cium-containing buffer (n = 68).
Enteric glial purinoceptor
ATP cogeners and related nucleotides were used to
characterize an enteric glial purinoceptor. Each pu-
rinergic receptor agonist was superfused for 250 s at
100 pM, and each glia] cell was exposed to only one
agonist. Based on the percentage of enteric glia re-
sponding with Ca24 fluxes, the rank order of potency
was UTP = ATP> ADP> ~3,y-MeATP > 2-MeS-
ATP = a,$-MeATP = AMP = adenosine (Fig. 5).
In responding glia, peak [Ca24 ]~levels achieved by
these ligands at 100 pM were as follows: UTP = 1,123
± 43 nM (n = 68) > ATP = 583 ±26 nM (n
= 139) > ADP = 223 ±26 nM (n = 65) > 73,y-
MeATP = 138 ± lOnM(n = 49). Both the percentage
of glia responding to purinergic agonists and the peak
[Ca2~]~ achieved by those ligands are consistent with
action at a glial P
2~(Dubyak, 1991) or “nucleotide”
(O’Connoret al., 1991) or P2.,,2 (Abbracchioand Burn-
stock, 1994) receptor.
Two P2 receptor antagonists were used to confirm
agonist studies. Suramin (300 pM), a trypanocidal
agent that has been shown to antagonize both P2x- and
P2w-mediated responses (Dunn and Blakely, 1988),
J. Neurochem., Vol. 66, No. 2, /996
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FIG. 5. Each purinergic receptor agonist was superfused for 250
sat 100 pM. Glia were judged to respond to an agonist if [Ca2~],increased by at least 100% over baseline values. The total num-
ber of glia examined was 385; each glial cell was exposed to
only one agonist.
did not inhibit ATP-evoked calcium transients (n
= 41; Fig. 6A). RB2, an anthraquinone sulfonic acid
derivative and specific P
2~,,antagonist (Bean, 1992),
also did not reduce ATP-mediated transients (n = 96;
Fig. 6B).
Enteric glia respond to ATP in the absence of
extracellular calcium
To identify the source(s) of calcium responsible for
ATP’s action, glia were superfused with ATP (100
pM) in calcium-free buffer plus EGTA. One hundred
percent of the glia responded with a peak [Ca
24], of
621 ± 21 nM (n = 48). Figure 7 shows a typical
tracing of a glial response to ATP in the absence of
extracellular calcium. The sustained elevation or pla-
teau following the sharp peak in calcium-containing
buffer is abolished incalcium-free buffer. These obser-
vations suggest that an influx of extracellular calcium
occurs during the plateau phase.
ATP and thapsigargin induce release of identical
calcium stores in enteric glia
To quantify the intracellular calcium store(s) re-
leased by ATP, glia were superfused with thapsigargin
followed by ATP or by ATP followed by thapsigargin.
Thapsigargin, a sesquiterpene lactone, is a highly se-
lective and potent inhibitor of endoplasmic reticulum
Ca24-ATPases, resulting in release of intracellular
stores of calcium (Thastrup et al., 1990). Of 89 glia
exposed to thapsigargin, 89 responded with increases
in [Ca24], and none responded to the subsequent ATP
superfusion (Fig. 8A). Fifty-two of 52 glia responded
to ATP (data not shown) following exposure to thapsi-
gargin epoxide, a negative control for thapsigargin
(Christensen et al., 1992). This implies that toxicity
from thapsigargin is not the reason for lack of glial
response to subsequent ATP superfusion.
ATP superfused repetitively in a calcium-free buffer
plus EGTA generated small increases in [Ca2~]
1 on
FIG. 6. Neither suramin (300 pM) nor RB2 (500 pM) inhibited
ATP-evoked calcium fluxes in enteric glia. Glia were superfused
with ATP (100 MM) for 60s, followed by 300 s of buffer, followed
by suramin (A) or RB2 (B) alone for 60 s and then the inhibitor
plus ATP for 60 s. These tracings are typical of 41(A) and 96
(B) glia.
the second and third exposure. None of 44 glia re-
sponded to thapsigargin superfused after three succes-
sive ATP exposures (Fig. 8B). These data suggest that
(a) an initial exposure to ATP in a calcium-free buffer
induces release of nearly all the intracellular calcium
sensitive to ATP; (b) thapsigargin and ATP induce
release of identical intracellular calcium stores; and (c)
FIG. 7. Glial response to ATP (100 pM, 250 s) in a calcium-free
buffer plus 1 mM EGTA. This tracing is typical of 48 cells.
J. Neurochem., Vo/. 66. No. 2, /996
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FIG. 9. Enteric glia were initially exposed to ATP (100 pM, 60
s), followed by 300 s of buffer, 60 s of U-73122 alone (10 pM),
and then U-731 22 plus ATP (100 pM) for 60 s. Percent inhibition
of ATP-evoked calcium flux calculated as per Materials and
Methods. This tracing is typical of 29 glia.
calcium fluxes by 93 ± 7% (n = 68; p < 0.05 vs.
second ATP exposure alone; Fig. 10). Preincubation of
enteric glia with 4aPMA (100 nM, 300 s), a negative
control (Duuren et al., 1979), had no effect (n = 8;
data not shown).
Effect of pertussis toxin
FIG. 8. A: Thapsigargin (10 pM) superfused for 500 sin calcium-
free buffer evoked calcium fluxes in enteric glia. Subsequent
exposure to ATP (100 pM, 60 s) did not generate responses in
these cells. B: ATP (100 pM, 60 s) was superfused repetitively
in a calcium-free buffer plus 1 mM EGTA. Each ATP exposure
was separated by 300 s of calcium-free buffer perfusion. Follow-
ing the ATP superfusions, thapsigargin (10 pM) was superfused
for 300 s. These tracings are typical of 89 (A) and 44 (B) glia.
ATP may release D-rnyo-inositol I ,4,5-trisphosphate-
sensitive calcium stores.
ATP activates PLC in enteric glia
The aminosteroid U-73 122 has been shown to in-
hibit PLC-coupled responses in a wide variety of cells
(Bleasdale and Fisher, 1993). Pretreatment of enteric
glia with U-73 122 (10 pM, 60 s) inhibited ATP-
evoked calcium transients by 92 ±8% (n = 29; p
< 0.05 vs. second ATP exposure alone; Fig. 9). U-
73343 (10 pM), an inactive analogue of U-73 122, had
no effect on ATP-evoked responses (a = 59, data not
shown), suggesting the effect of U-73l22 was not due
to nonspecific cell toxicity.
Phorhol ester inhibits ATP-evoked calcium
transients
Phorbol ester inhibition of both nucleotide-evoked
calcium transients and D-myo-inositol I ,4,5-trisphos-
phate accumulation have been reported in rat glioma
cells (Munshi et al., 1993) and a neuronal cell line
(Iredale et al., 1992). Brief preincubation of enteric
glia with PMA (100 nM, 300 s) inhibited ATP-evoked
P20 receptors couple to PLC either partially through
pertussis toxin-sensitive C proteins (Erb et al., 1993)
or exclusively through toxin-insensitive C proteins
(Munshi et al., 1993). Enteric glia were preincubated
with pertussis toxin at 100 ng/ml for 24 h. No signifi-
cant difference in peak [Ca
24I~was seen on ATP su
perfusion (100 pM) between pertussis toxin-treated
glia (peak [Ca24]
1 = 621 ± 76nM, n =43)vs. control
gha (peak [Ca
24]
1 = 577 ±99 nM, n = 37).
DISCUSSION
This study suggests that (a) cultured enteric glia,
like glia of the CNS and PNS, exhibit neuroligand
signal transduction systems linked to increases in cyto-
solic calcium levels; (b) enteric glia in vitro are phar-
FIG. 10. Enteric glia were initially exposed to ATP (100 pM, 60
s), followed by 200 s of buffer, 300 s of PMA alone (100 nM),
and then PMA plus ATP (100 pM) for 60s. Percent inhibition of
ATP-evoked calcium flux was calculated as per Materials and
Methods. This tracing is typical of 48 glia.
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macologically heterogeneous; (c) enteric glia possess
at least a P20 receptor for ATP; and (d) ATP-evoked
Ca
2~fluxes in enteric glia are couple by a pertussis
toxin-insensitive mechanism to activation of PLC and
release of D-myo-inositol I ,4,5-trisphosphate-sensitive
calcium stores.
Enteric glia, originating from the neural crest, have
been characterized using ultrastructural, immunocyto-
chemical, and molecular techniques. Studies with thin-
section electron microscopy have revealed an intimate
association between enteric glial and neuronal mem-
branes, with numerous specialized contacts of un-
known significance between the two cell types (Gabella,
1981). In addition to staining strongly for GFAP, en-
teric glia, like astrocytes, express the enzyme gluta-
mine synthetase, the antigen Ran-2 (Jessen and Mir-
sky, 1983), and the Ca24 binding protein 5-100 (Fern
et al., 1982).
This work extends prior characterization of cultured
enteric glia and raises new possibilities for their func-
tion. Although glia of the CNS and PNS respond to
various neurotransmitters, responses of enteric glia
have not previously been examined. Fura-2-loaded
type I and type 2 astroglia exhibit calcium signaling
in response to 2-methylthio-ATP, ATP, carbachol, se-
rotonin, glutamate, and histamine (Dave et al., 1991;
McCarthy and Salm, 1991; Kastritsis et al., 1992).
Likewise, oligodendroglia express neuroligand recep-
tors linked to calcium mobilization; responses to ATP,
glutamate, norepinephrine, histamine, bradykinin, car-
bachol, and substance P have been reported (Kastritsis
and McCarthy, 1993). In contrast to CNS glia, periph-
eral glia such as Schwann cells have displayed negligi-
ble or only partial responses to neuroligands such as
bradykinin, histamine, and glutamate, whereas nearly
all responded to ATP (Lyons et a]., 1994). Regarding
responses to neurotransmitters, enteric glia appear
more like peripheral than central glia, despite estab-
lished similarities between enteric glia and astrocytes
in expression of cytoskeletal and other proteins. En-
teric glia did not respond to glutamate, norepinephrine,
carbachol, or substance P. Minor subpopulations of
enteric glia responded to bradykinin, histamine, and
serotonin, whereas all cells examined responded to
ATP. Whether enteric glia in vivo demonstrate dif-
fering neurotransmitter responsiveness is unknown.
Differences in membrane properties of glia in vitro
versus in situ have been reported: Optic nerve type I
astrocytes express fewer types of ion channels in cul-
ture than in situ (Barres et al., 1990).
This report suggests that enteric glia are pharmaco-
logically heterogeneous, supporting the few previous
observations of enteric glial variability. For example,
a minor subgroup of cultured enteric glia stain posi-
tively for Leu 7, a monoclonal antibody that recognizes
specific adhesion cell molecules (Bannerman et al.,
1987). Likewise, the monoclonal antibody anti-
GFAP3, which recognizes GFAP-containing interme-
diate filaments in astrocytes, binds selectively to a sub-
group of enteric glia (Jessen and Mirsky, 1985). In
this study, discrete subpopulations of enteric glia re-
sponded with calcium signaling to serotonin (4%), bra-
dykinin (11%), histamine (31%), and ATP (100%).
It is likely that differences in receptor expression ac-
count for these variations in responsiveness, although
differences in signaling pathways distal to the receptor
could also be a factor. It is possible that cultured enteric
glia isolated from elsewhere along the gastrointestinal
tract would demonstrate different responsiveness, as
astroglial properties and functions vary depending on
their location within the brain (Murphy and Pearce,
1987).
Based on the actions of purinoceptor agonists, enteric
glia possess at least a P
20 receptor subtype for ATP.
Purinergic receptors were first classified in 1978 (Burn-
stock) as P1 (adenosine) and P2 (ATP/ADP), with
many new subclasses being defined since that time. Ab-
bracchio and Bumstock (1994) have recently put forth
a new framework for P2 receptors, suggesting that the
variously named P2 purinoceptors that are C protein
coupled should be incorporated into numbered sub-
classes of the P2~,,family. Thus, the recently cloned P20
receptor (Erb et al., 1993; Lustig et al., 1993) would
be renamed P2~,,2.This receptor, which will continue to
be referred to as P20 for the purposes of this article, has
been expressed in a human cell line where its actions
are independent of extracellular calcium and partially
pertussis toxin sensitive (Erb et al., 1993; Lustig et al.,
1993). It has been localized to cells as diverse as human
neutrophils, human skin fibroblasts, aortic smooth mus-
cle cells, pulmonary artery endothelium, and renal corti-
cal collecting tubule (for review, see O’Connor et al.,
1991). Some cells, such as the C6 glioma line (Lin
and Chuang, 1994) have a P2 receptor plus a second
purinoceptor, with more than one signal transduction
mechanism activated on ATP binding. P20 receptoracti-
vation is linked to varied processes, including prosta-
glandin production in adrenal medulla endothelial cells,
neutrophil superoxide release, and relaxation of rat aorta
(O’Connor et al., 1991).
The enteric glial P20 receptor and its calcium signal-
ing pathway display both similarities and differences
compared with other described P20 receptors. As in
enteric glia, the C6 glioma P20 receptor is linked to
PLC by a pertussis toxin-insensitive mechanism (Lin
and Chuang, 1994). However, suramin was a competi-
tive antagonist for the C6 glioma receptor, whereas it
had no effect in enteric glia. Like enteric glia, increases
in levels of cytosolic calcium and D-myo-inositol I ,4,5-
trisphosphate are stimulated by a P20 receptor in bovine
glomerular endothelial cells (Briner and Kern, 1994).
The P20 receptor in NO 108-15 cells, a neuroblastoma/
glioma hybrid line, has been linked not only to PLC
activation, but also to a plasma membrane calcium
channel, because chelation of extracellular calcium by
EGTA reduced ATP-evoked [Ca
2~]~increases by 40%
(Lin et al., 1993).
Experiments using inhibitors, e.g., U-73 122 and
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PMA, were performed by comparing the peak Ca2t
response of the second ATP exposure in the presence
of the inhibitor to the peak Ca2~response to ATP
expected in the absence of the inhibitor. Based on mul-
tiple observations, there was a 41% decrease in peak
Ca24], between the first and second ATP exposures
(n = 68; Fig. 4). Decreases in peak [Ca24], observed
in the presenceof the inhibitors, e.g., 92 ±8% decrease
with U-73 122, were thus compared with this expected
decrement. Decreases in responsiveness on repetitive
stimulation have been seen with several receptors
linked to phosphoinositide hydrolysis (Sugiya et al.,
1987; Munshi et al., 1993). One potential complication
in data interpretation using this experimental paradigm
is that the inhibitors may be affecting calcium influx
rather than the D-myo-inositol 1 ,4,5-trisphosphate-me-
diated release of calcium from intracellular stores. The
compound U-73 122 has been extensively characterized
(Bleasdale and Fisher, 1993) as an inhibitor of phos-
phoinositide-specific PLC, with little or no direct inhi-
hition of phospholipases A
2 and D. Experiments by
other investigators have demonstrated rapid inhibition
of Ca
24 o cillations with U-73 122 in the presence f
lanthanum, indicating that U-73l22 was unlikely to
inhibit Ca24 oscillations by interfering with Ca24 in-
flux (Yule and Williams, 1992). Furthermore, experi-
ments using thapsigargin ruled out the possibility that
U-73 122 functioned to interfere with the storage or
release of Ca24 in pancreatic acini (Yule and Williams,
1992). Thus, although we cannot rule out potential
effects of inhibitors on Ca24 influx pathways, our re-
sults using inhibitors are consistent with previously
published actions of these compounds on the phospho-
inositol pathway.
Reported functions of neuroligand-responsive glia
from the CNS and PNS include regulation of energy
metabolism, synthesis and releaseof neurotransmitters,
and buffering of electrolytes. Neuroligands such as se-
rotonin, histamine, and vasoactive intestinal peptide
activate enzymatic breakdown of [3H]glycogen stores
in astrocytes (Pentreath et al., 1986). It has been sug-
gested that neighboring neurons use the products of
astroglial glycogen turnover as energy sources (Shank
and Campbell, 1984). Furthermore, because astrocytes
have ion channels, they are believed to participate in
electrolyte homeostasis, thus controlling the neuronal
microenvironment (Cserr and Bundgaard, 1986). Spe-
cifically, astrocytes regulate extracellular K4 levels by
taking up excess potassium, redistributing it through
extensive gap junctions, and releasing it into the blood-
stream (Newman, 1986). Thus, CNS glia could be
involved in information processing by modulating lo-
cal amine and ion concentrations. Whether enteric glia
possess such neuromodulatory functions remains to be
determined.
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